Ironwood Pharmaceuticals, Inc. Class A Common Stock (I76)
Munich
Closed
Aug 25, 2026
Day's Range
3.6252 wk Range
0.9650Overview - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
382.34M
P/E (Trailing)
‪24.66‬
PEG Ratio
‪0.23‬
Price / Book
‪-3.75‬
EV / EBITDA
‪3.06‬
Profitability
Operating Margin
‪34.70%‬
Return on Assets
‪6.05%‬
Return on Equity
‪-9.17%‬
Ownership
Shares Outstanding
165.23M
Price stats
50-Day Avg
‪3.55‬
200-Day Avg
‪3.38‬
Peers - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Munich.
- I76MunichIronwood Pharmaceuticals Inc.+69.73%52-week change24.67P/E (Trailing)—Profit Margin
- 3KFMunichAuxly Cannabis Group Inc.+94.35%52-week change4.53P/E (Trailing)‪57.26%‬Profit Margin
- HLSMunichAIC Mines Limited+64.23%52-week change—P/E (Trailing)—Profit Margin
- PA8MunichPaion AG+81.23%52-week change-0.81P/E (Trailing)‪94.10%‬Profit Margin
- 6CWMunichCharlottes Web Holdings Inc.+69.64%52-week change-1.47P/E (Trailing)‪43.48%‬Profit Margin
- E7PMunichIndivior Pharmaceuticals, Inc.+62.36%52-week change21.19P/E (Trailing)‪80.14%‬Profit Margin
- 29TAMunichTherapeuticsMD, Inc.+49.73%52-week change-37.80P/E (Trailing)—Profit Margin
Profile Summary - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
About
Ironwood Pharmaceuticals Inc. is a healthcare and pharmaceuticals company specializing in the development and commercialization of drugs for gastrointestinal conditions. Headquartered in Cambridge, Massachusetts, Ironwood focuses on designing novel treatments that address unmet medical needs, particularly for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
